StonvexLoading…
StonvexStonvexStonvexCore line items from CHCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $74.29M | $71.99M | $69.07M | $68.10M |
Operating Income | $161.47M | $144.52M | $143.11M | $127.33M |
Net Income | $130.49M | $117.10M | $114.36M | $102.07M |
EPS (Diluted) | $8.93 | $7.89 | $7.61 | $6.80 |
Total Assets | $6.72B | $6.46B | $6.17B | $5.88B |
Total Liabilities | $5.91B | $5.73B | $5.49B | $5.30B |
Cash & Equivalents | $191.92M | $225.39M | $156.28M | $200.00M |
Free Cash Flow OCF − CapEx | $128.45M | $129.19M | $134.62M | $113.68M |
Shares Outstanding | 14.48M | 14.70M | 14.89M | 14.87M |